This compound is a sulfonylated nitro-triazole reagent used as a pharmaceutical intermediate in oligonucleotide synthesis. Its structure features a triazole ring with a nitro group and a mesitylenesulfonyl substituent, contributing to its role in nucleoside activation chemistry.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 74257-00-4
5'-DMT-PseudoUridine
Pharmaceutical intermediate for oligonucleotide synthesis
1-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione
Pharmaceutical intermediate for oligonucleotide synthesis
(S)-GNA-A(Bz)-phosphoramidite
Pharmaceutical intermediate for oligonucleotide synthesis
(S)-GNA-C(Bz)-phosphoramidite
Pharmaceutical intermediate for oligonucleotide synthesis
(4-nitrophenyl)methyl (5R,6S)-6-[(1R)-1-hydroxyethyl]-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate
Pharmaceutical intermediate for imipenem
2-amino-3-bromo-5-methylpyrazine
pharmaceutical intermediate
Methyl-d3-amine hydrochloride
pharmaceutical intermediate
3-Bromo-1H-pyrrolo[2,3-b]pyridine
pharmaceutical intermediate
3-nitro-1-(2,4,6-trimethylphenyl)sulfonyl-1,2,4-triazole
SFYDWLYPIXHPML-UHFFFAOYSA-N
CC1=CC(=C(C(=C1)C)S(=O)(=O)N2C=NC(=N2)[N+](=O)[O-])C